Chronic Pain
Conditions
Brief summary
This is a prospective, pre post, pilot cohort study to be conducted in patients with chronic pain, which is defined as pain that lasts beyond 3 months. To accomplish the primary and secondary objectives of the study, three phrases will be designed and completed during three months
Detailed description
This study will evaluate the effectiveness of community-based pharmacist interventions on the quality of life of patients with chronic pain as determined by self-reported pain levels using an established scoring system. Participating pharmacists will enroll chronic pain patients from their normal practice to receive a consultation, which consists of an assessment of their current pain, a medication review, and education about their condition. Based on the information provided by the patient, the pharmacist will prepare a care plan, contact the patient's prescriber, and, in conjunction with the prescriber, implement the plan to help relieve their pain. Follow-up assessments will be done after 2 weeks, and 3 months.
Interventions
OTHERmedication reviews, assessment, recommendations, education.
Sponsors
University of Waterloo
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Aged 18 or older 2. Baseline average pain intensity using Brief Pain Inventory is 6 or higher 3. Ambulatory and able to attend the intervention 4. Complaining of pain for 3 months or longer
Exclusion criteria
1. Patients with malignant or cancer pain 2. Patients who are unable to communicate in English 3. Non-ambulatory and unable to attend the intervention at the participating site 4. Unable to give informed consent.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain intensity change | baseline, 2 weeks follow-up, 3 months follow-up | Pain intensity will be measured with Brief Pain Inventory pain intensity subscale, and will be measured 3 times in total |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pain interference | baseline, 2 weeks follow-up, 3 months follow-up | Pain interference will be measured with Brief Pain Inventory pain interference subscale, and will be measured 3 times in total |
| Quality of life change | baseline, 3 months follow-up | quality of life will be measured using Short Form-36, and will be measured twice in total. |
Other
| Measure | Time frame | Description |
|---|---|---|
| patient adherence | 2 weeks follow-up and 3 months follow-up | Patient adherence will be measured using Morisky medication adherence scale-8, and will be measured at 2 weeks and 3 months follow-up.The Morisky medication adherence scale-8 will be used as supplementary data to further elucidate potential factors behind the observed outcomes. |
Countries
Canada
Outcome results
None listed